Cuban's Pharma Disruption

Mark Cuban is shaking up the pharmaceutical industry with his new company that offers generic drugs at significantly lower prices—only a 15% markup compared to the typical 100% seen in the market. The discussion reveals how he may be cutting out middlemen and potentially importing drugs to achieve these savings. The contrast between drug prices in the U.S. and other countries highlights the ongoing issues within the American healthcare system.